PortfoliosLab logo

Aprea Therapeutics, Inc. (APRE)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS03836J1025
CUSIP03836J102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.86
Year Range$0.63 - $5.63
EMA (50)$1.06
EMA (200)$2.52
Average Volume$398.98K
Market Capitalization$20.03M

APREShare Price Chart


Chart placeholderClick Calculate to get results

APREPerformance

The chart shows the growth of $10,000 invested in Aprea Therapeutics, Inc. on Oct 4, 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $418 for a total return of roughly -95.82%. All prices are adjusted for splits and dividends.


APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

APREReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M4.39%-6.21%
YTD-70.17%-18.17%
6M-74.60%-17.47%
1Y-82.95%-8.89%
5Y-68.81%11.33%
10Y-68.81%11.33%

APREMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

APRESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aprea Therapeutics, Inc. Sharpe ratio is -1.01. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

APREDividend History


Aprea Therapeutics, Inc. doesn't pay dividends

APREDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

APREWorst Drawdowns

The table below shows the maximum drawdowns of the Aprea Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aprea Therapeutics, Inc. is 98.74%, recorded on May 18, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.74%Dec 30, 2019602May 18, 2022
-24.77%Nov 20, 20195Nov 26, 20199Dec 10, 201914
-17.45%Dec 13, 20194Dec 18, 20194Dec 24, 20198
-8.92%Oct 22, 20197Oct 30, 201911Nov 14, 201918
-7.61%Oct 4, 20193Oct 8, 20198Oct 18, 201911
-0.9%Nov 18, 20191Nov 18, 20191Nov 19, 20192

APREVolatility Chart

Current Aprea Therapeutics, Inc. volatility is 68.45%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Aprea Therapeutics, Inc.


Loading data...